The tumor-suppressive role of FMRP in HER2-positive breast cancer may be linked to its regulation of ECM homeostasis or specific mRNA targets that differ from its oncogenic functions in other subtypes, potentially influenced by HER2 signaling or TME interactions. This evidence concerns the gene FMR1 and neoplasm.